Diversity of inorganic arsenite biotransformation

Biological Trace Element Research

Volumn 68, Issue 3, 1999, Pages 249-266

  Healy, Sheila M ^a   Wildfang, Eric ^a   Zakharyan, Robert A ^a   Aposhian, H Vasken ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Arsenic; Biotransformation; Diversity

Indexed keywords

ARSENIC ACID DERIVATIVE; ARSENIC TRIOXIDE; INORGANIC COMPOUND; METHYLTRANSFERASE;

ARTICLE; BIODIVERSITY; BIOTRANSFORMATION; CATALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INDUCTION; ENZYME PURIFICATION; HAMSTER; METHYLATION; MOUSE; NONHUMAN; OXIDATION; RABBIT; REACTION ANALYSIS; RHESUS MONKEY; TISSUE DISTRIBUTION;

ANIMALIA; CRICETINAE; MACACA MULATTA; MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0032952593     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02783907     Document Type: Article

References (65)

1. 1. B. Venugopal and T. D. Luckey, Metal Toxicity in Mammals, Plenum, New York (1978).
2. 2. E. Marafante and M. Vahter, Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster, Environ. Res. 42, 72-82 (1987).
3. 3. H. B. F. Dixon, The biochemical action of arsonic acids especially as phosphate analogues, Adv. Inorg. Chem. 44, 191-227 (1996).
4. 4. J. L. Webb, Arsenicals, in Enzyme and Metabolic Inhibitors, vol. 3, Academic, New York, pp. 595-819 (1966).
5. 5. M. J. Kosnett, Arsenic, in Poisoning and Drug Overdose, K. R. Olson, ed., Appleton & Lange, Norwalk, CT, pp. 87-89 (1994).
6. 6. H. V. Aposhian, Biochemical toxicology of arsenic, in Reviews in Biochemical Toxicology, E. Hodgson, J. R. Bend and R. M. Philpot, eds., Elsevier, Amsterdam, pp. 265-299 (1989).
7. 7. E. Marafante, M. Vahter, and J. Envall, The role of the methylation in the detoxification of arsenate in the rabbit, Chem.-Biol. Interact. 56, 225-238 (1985).
8. 8. S. L. Winski and D. E. Carter, Interactions of rat red blood cell sulfhydryls with arsenate and arsenite, J. Toxicol. Environ. Health 46, 379-397 (1995).
9. 9. S. A. Lerman, T W. Clarkson, and R. J. Gerson, Arsenic uptake and metabolism by liver cells is dependent on arsenic oxidation state, Chem.-Biol. Interact. 45, 401-406 (1983).
10. 74As]-arsenite in mice and rabbits, Chem.-Biol. Interact. 50, 49-57 (1984).
11. 11. J. P. Buchet and R. Lauwerys, Study of inorganic arsenic methylation by rat liver in vitro: relevance for the interpretation of observations in man, Arch. Toxicol. 57, 125-129 (1985).
12. 12. R. Zakharyan, Y. Wu, G. M. Bogdan, and H. V. Aposhian, Enzymatic methylation of arsenic compounds: I. Assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver, Chem. Res. Toxicol. 8, 1029-1038 (1995).
13. 13. M. Styblo, M. Delnomdedieu, and D. J. Thomas, Mono-and dimethylation of arsenic in rat liver cytosol in vitro, Chem.-Biol. Interact. 99, 147-164 (1996).
14. 14. E. Marafante, M. Vahter, H. Norin, J. Envall, M. Sandstrom, A. Christakopoulos, et al., Biotransformation of dimethylarsinic acid in mouse, hamster and man, J. Appl. Toxicol. 7, 111-117 (1987).
15. 15. G. Morel, J. L. Cluet, P. Telolahy, H. M. Yang, N. Thieffry, and J. de Ceaurriz, Interindividual variability in the urinary excretion of inorganic arsenic metabolites by C57 BL/6J mice: possible involvement of a thiol/disulfide exchange mechanism, Toxicol. Lett. 78, 111-117 (1995).
16. 16. M. Vahter, G. Concha, B. Nermell, R. Nilsson, F. Dulout, and A. T. Natarajan, A unique metabolism of inorganic arsenic in native Andean women, Eur. J. Pharm. 293, 455-462 (1995).
17. 74As-labeled arsenate in rabbits, Fund. Appl. Toxicol. 34, 240-248 (1996).
18. 18. S. M. Healy, R. A. Zakharyan, and H. V. Aposhian, Enzymatic methylation of arsenic compounds: IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig, Mutat. Res. 386, 229-239 (1997).
19. 74As-arsenite, Arch. Toxicol. 51, 65-77 (1982).
20. 20. M. Vahter, R. Couch, B. Nermell, and R. Nilsson, Lack of methylation of inorganic arsenic in the chimpanzee, Toxicol. Appl. Pharmacol. 133, 262-268 (1995).
21. 21. R. A. Zakharyan, E. Wildfang, and H. V. Aposhian, Enzymatic methylation of arsenic compounds: III. The marmoset and tamarin, but not the rhesus, monkeys are deficient in methyltransferases that methylate inorganic arsenic, Toxicol. Appl. Pharmacol. 140, 77-84 (1996).
22. 22. H. V. Aposhian, Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity, Annu. Rev. Pharmacol. Toxicol. 37, 397-419 (1997).
23. 23. A. W. Fitchett, E. H. Daughtrey, Jr., and P. Mushak, Quantitative measurements of inorganic and organic arsenic by flameless atomic absorption spectrometry, Anal. Chim. Acta 79, 93-99 (1975).
24. 24. M. S. Smith, P. R. Jones, and D. Y. Shirachi, Some factors involved in the hydride generation of alkylarsrines, Toxicologist 12, 338 (1992).
25. 25. D. Y. Shirachi, M. S. Smith, and P. R. Jones, The effect of temperature on the volatilization of alkylarsines during posthydride generation as monitered by mass spectrometry, Toxicologist 12, 339 (1992).
26. 26. J. Chappell, B. Chiswell, and H. Olszowy, Speciation of arsenic in a contaminated soil by solvent extraction, Talanta 42, 323-329 (1995).
27. 27. G. M. Bogdan, A. Sampayo-Reyes, and H. V. Aposhian, Arsenic binding proteins of mammalian systems: I. Isolation of three arsenite-binding proteins of rabbit liver, Toxicology 93, 175-193 (1994).
28. 28. M. Styblo, H. Yamauchi, and D. J. Thomas, Comparative in vitro methylation of trivalent and pentavalent arsenicals, Toxicol. Appl. Pharmacol. 135, 172-178 (1995).
29. 29. N. Scott, K. M. Hatlelid, N. E. MacKenzie, and D. E. Carter, Reactions of arsenic (III) and arsenic (V) species with glutathione, Chem. Res. Toxicol. 6, 102-106 (1993).
30. 30. M. Delnomdedieu, M. M. Basti, J. D. Otvos, and D. J. Thomas, Reduction and binding of arsenate and dimethylarsinate by glutathione: a magnetic resonance study, Chem.-Biol. Interact. 90, 139-155 (1994).
31. 31. E. Wildfang, R. A. Zakharyan, and H. V. Aposhian, Enzymatic methylation of arsenic compounds. VI. Characterization of hamster liver arsenite and methylarsonic acid methyltransferase activities in vitro, Toxicol. App. Pharmacol. 152, 366-375.
32. 32. N. D. Ridgeway and D. E. Vance, Purification of phosphatidylethanolamine N-methyltransferase from rat liver, J. Biol. Chem. 262, 17231-17239 (1987).
33. 33. J. P. Buchet and R. Lauwerys, Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol, Biochem. Pharmacol. 37, 3149-3153 (1988).
34. 34. M. Hirata, A. Tanaka, A. Hisanaga, and N. Ishinishi, Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters, Toxicol. Appl. Pharmacol. 106, 469-481 (1990).
35. 35. M. Vahter and E. Marafante, Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit, Toxicol. Lett. 37, 41-46 (1987).
36. 36. M. Vahter and E. Marafante, In vivo methylation and detoxication of arsenic, in The Biological Alkylation of Heavy Elements, P. J. Craig and F. Glocking, eds., Royal Society of Chemistry, London, pp. 105-119 (1988).
37. 37. R. M. Maiorino and H. V. Aposhian, Dimercapto metal-binding agents influence the biotransformation of arsenite in the rabbit, Toxicol. Appl. Pharmacol. 77, 240-250 (1985).
38. 38. US EPA, The Expert Panel on Arsenic Carcinogenicity, National Center for Environmental Assessment, US EPA, Washington, DC (1997).
39. 39. M. Vahter, Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats, Environ. Res. 25, 286-293 (1981).
40. 40. S. M. Charbonneau, G. K. H. Tam, F. Bryce, and B. Collins, Pharmacokinetics and metabolism of inorganic arsenic in the dog, in Trace Substances in Environmental Health, Vol. 12, University of Missouri, D. D. Hemphill, ed., Columbia, MO, pp. 276-283 (1978).
41. 41. S. M. Charbonneau, G. K. H. Tam, F. Bryce, Z. Zawidzka, and E. Sandi, Metabolism of orally administered inorganic arsenic in the dog, Toxicol. Lett. 3, 107-113 (1979).
42. 42. M. Hirata, T. Mohri, A. Hisanaga, and N. Ishinishi, Conversion of arsenite and arsenate to methylarsenic and dimethylarsenic compounds by homogenates prepared from livers and kidneys of rats and mice, Appl. Organomet. Chem. 3, 335-341 (1989).
43. 43. B. Georis, A. Cardenas, J. P. Buchet, and R. Lauwerys, Inorganic arsenic methylation by rat tissue slices, Toxicology 63, 73-84 (1990).
44. 44. F. T. Hunter, A. F. Kip, and J. W. Irvine, Jr., Radioactive tracer studies on arsenic injected as potassium arsenite. I. Excretion and localization in tissues, J. Pharmacol. Exp. Ther. 76, 207-220 (1942).
45. 45. O. H. Lowry, F. T. Hunter, A. F. Kip, and J. W. Irvine, Jr., Radioactive tracer studies on arsenic injected as potassium arsenite. II. Chemical distribution in tissues, J. Pharmacol. 76, 221-225 (1942).
46. 74 as a tracer, Univ. Calif. Publ. Pharmacol. 2, 263-282 (1950).
47. 74As-arsenite or -arsenate, Acta Pharmacol. Toxicol. 51, 253-265 (1982).
48. 48. J-H. Li and T. G. Rossman, Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis, Mol. Toxicol. 2, 1-9 (1989).
49. 49. R. C. Lantz, G. Parliman, G. J. Chen, and D. E. Carter, Effect of arsenic exposure on alveolar macrophage function. I. Effect of soluble As (III) and As (V), Environ. Res. 67, 183-195 (1994).
50. 50. S. A. Lerman and T. W. Clarkson, The metabolism of arsenite and arsenate by the rat, Fundam. Appl. Toxicol. 3, 309-314 (1983).
51. 51. L. Dallaire and R. Beliveau, Phosphate transport by capillaries of the blood-brain barrier, J. Biol. Chem. 267, 22323-22327 (1992).
52. 52. V. P. Kamboj and A. B. Kar, Antitesticular effect of metallic and rare earth salts, J. Reprod. Fertil. 7, 21-28 (1964).
53. 53. T. Espevik, M. K. Lamvik, A. Sunde, and K. B. Eik-Nes, Effects of cadmium on survival and morphology of cultured rat Sertoli cells, J. Reprod. Fertil. 65, 489-495 (1982).
54. 54. S. M. Healy, E. A. Casarez, F. Ayala-Fierro, and H. V. Aposhian, Enzymatic methylation of arsenic compounds V: Arsenite methyltransferase activity in tissues of mice, Toxicol. Appl. Pharmacol. 148, 65-70 (1998).
55. 55. D. Baron, I. Kunick, I. Frischmuth, and J. Petres, Further in vitro studies on the biochemistry of the inhibition of nucleic acid and protein synthesis induced by arsenic, Arch. Dermatol. Res. 253, 15-22 (1975).
56. 56. H. E. Roscoe, On the alleged practice of arsenic-eating in Styria, Memoirs of the Literary and Philosophical Society of Manchester, 1, 208-221 (1862).
57. 57. C. Maclagan, On the arsenic-eaters of Styria, Edinburgh Med. J. 10, 200-207 (1864).
58. 58. V. Bencko and K. Symon, Dynamics of arsenic cumulation in hairless mice after per-oral administration, J. Hyg. Epidemiol. Microbiol. Immunol. 13, 248-253 (1969).
59. 74As) in mice preliminarily exposed to the element in drinking water: a study in arsenic tolerance, J. Hyg. Epidemiol. Microbiol. Immunol. 17, 165-168 (1973).
60. 60. M. F. Hughes and D. J. Thompson, Subchronic dispositional and toxicological effects of arsenate administered in drinking water to mice, J. Toxicol. Environ. Health 49, 101-120 (1996).
61. 61. A. Albores, J. Koropatnick, M. G. Cherian, and A. J. Zelazowski, Arsenic induces and enhances rat hepatic metallothionein production in vivo, Chem.-Biol. Interact. 85, 127-140 (1992).
62. 74As, Anal. Biochem. 86, 505-511 (1978).
63. 63. E. A. Crecelius, Changes in the chemical speciation of arsenic following ingestion by man, Environ. Health Perspect. 19, 147-150 (1977).
64. 64. M. Vahter, Species differences in the metabolism of arsenic compounds, Appl. Organomet. Chem. 8, 175-182 (1994).
65. 65. H. V. Aposhian, R. A. Zakharyan, Y. Wu, S. Healy, and M. M. Aposhian, Enzymatic methylation of arsenic compounds: II. An overview, in Arsenic Exposure and Health Effects, Vol. 2, C. Abernathy, R. Calderon and W. Chappell, eds., Chapman & Hall, London, pp. 296-321 (1997).